Compare LNN & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNN | TNDM |
|---|---|---|
| Founded | 1954 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1995 | 2013 |
| Metric | LNN | TNDM |
|---|---|---|
| Price | $129.30 | $21.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 19 |
| Target Price | ★ $128.00 | $27.05 |
| AVG Volume (30 Days) | 59.8K | ★ 2.4M |
| Earning Date | 04-09-2026 | 05-19-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 12.81 | N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | $676,368,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | N/A | $10.96 |
| Revenue Next Year | $5.91 | $9.33 |
| P/E Ratio | $85.21 | ★ N/A |
| Revenue Growth | ★ 11.41 | 7.93 |
| 52 Week Low | $106.10 | $10.00 |
| 52 Week High | $149.56 | $29.65 |
| Indicator | LNN | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 42.77 | 45.19 |
| Support Level | $116.15 | $19.04 |
| Resistance Level | $142.73 | $22.98 |
| Average True Range (ATR) | 4.75 | 1.78 |
| MACD | -0.96 | -0.18 |
| Stochastic Oscillator | 14.11 | 29.36 |
Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.